CDSCO Issues an Alert for 49 Drugs, Including Aspirin and Vitamin D3
Written by Arushi Sharma, Susi
CDSCO discovered 48 substandard drugs and 1 spurious drug out of 1273 tested in June, including treatments for blood clots, asthma, high blood pressure, and more.
CDSCO found 48 drugs substandard and one spurious out of 1273 drugs tested in June. The alert list includes Rantidine Tablets, Rosuvastatin, Vitamin D3 Tablets, Erythromycin Stearate Tablets IP, Paracetamol Tablets, Telmisartan, and Albendazole. The spurious drug is Heparin injection for blood clot treatment.
CDSCO found 48 drugs below standard and one fake out of 1273 tested in June. Some were made by Himachal Pradesh pharmaceutical units. Flutrol 250 inhalation, used for asthma patients, had insufficient content, according to the drug regulator.
The highlighted drugs have various uses like preventing and treating blood clots, asthma, high blood pressure, heart-related swelling, cough, and peptic ulcers. There are also two nutritional supplements in the list, one used for preventing hair loss and another for forming red blood cells.
Drug regulator flagged drugs from Maxheal Pharmaceuticals, Zee Laboratories, Hindustan Antibiotics Ltd., Cadila Pharmaceuticals, and Alkem Health Science due to failed dissolution tests or insufficient active ingredient amounts. Zee Labs and Wings Pharma face partial/full manufacturing stops.
In the Parliament session, Minister Bharati Pravin Pawar from the Ministry of Health and Family Welfare revealed that in 2021-22, they tested 88,844 drug samples in the country. Out of these, 2,545 were found to be of substandard